Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

May 11, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • SARS-CoV-2
  • Page 7

Tag: SARS-CoV-2

  • BiotechToday
  • World

Mesenchymal Stem Cells Used in SARS-CoV-2 Patients Show Promising Results

bioxone January 11, 2021January 11, 2021 1

Sumedha Guha, Techno India University A ground-breaking randomized trial at the University Of Miami Miller School Of Medicine has given us a new treatment for SARS-CoV-2 patients. In the trial that was led by Dr. Camillo Ricordi, M.D., mesenchymal stem cells of the umbilical cord were infused into the body of patients severely affected by […]

Read More
  • BiotechToday
  • World

An aid to the pandemic: Development of the low-cost, highly efficient ventilator by UK scientists

bioxone January 6, 2021January 6, 2021 1

Ayooshi Mitra, Amity University, Kolkata A small but important aspect of managing a pandemic virus infection that affects the lungs, including SARS-CoV-1, SARS-CoV-2 (COVID-19), and influenza, is mechanical ventilation. Generally, ventilators are costly, difficult to maintain, and need considerable training to use. The majority of ventilators rely on high-flow oxygen and medically pure compressed air […]

Read More
  • BiotechToday
  • World

Alcohol-free hand sanitizers found to be as effective as alcohol-based ones

bioxone December 18, 2020December 18, 2020 1

Aishila Kar, Amity University Kolkata Sanitizers play an important role in this era of controlling COVID infection. It is well known that the Centres for Disease Control and Prevention (CDC) and the U.S. Food and Drug Administration (FDA) strongly recommend the use of alcohol-based sanitizers for prevention against SARS-CoV-2. However, scientists at Brigham Young University […]

Read More
  • BiotechToday
  • India

Variation of SARS-CoV-2 genomes in populations due to RNA editing enzymes

bioxone December 14, 2020December 14, 2020 2

Prama Ghosh, Amity University Kolkata The SARS-CoV-2 virus has infected millions around the globe since its transmission in the human host. Extensive diversification of the virus including significant molecular differences has resulted in failure to diagnose the virus. The virus undergoes continuous evolution and adaptation inside the body of the host, which helps it to survive […]

Read More
  • BiotechToday
  • India

Innovative Indian Ventilator Devices to tackle COVID-19

bioxone December 11, 2020December 10, 2020

Richismita Hazra, Amity University Kolkata The nationwide “Innovate2BeatCOVID” Grand Challenge has been won by three innovative ‘Ventilators and other respiratory Solutions’. This event was conducted by Marico innovation Foundation (MIF) and has awarded 85 lakhs in grants to the winners. These devices, made in India are affordable, disruptive and easily accessible. The use of best-in-class […]

Read More
  • BiotechToday
  • World

Viruses in the air – Biosensor detection!

bioxone December 8, 2020December 8, 2020 1

Parnad Basu, Amity University Kolkata Scientists never stop researching something until they can find effective and affordable methods to fight the problems. Biosensors are devices that are used to detect the presence or concentration of an analyte. Scientists have been trying to use biosensor to detect viruses and bacteria. Biosensors can be of several types, […]

Read More
  • BiotechToday
  • World

Food Inhibiting Enzyme That Causes COVID Replication

bioxone December 8, 2020December 8, 2020 1

Thota Kanishka Rao, Amity University Kolkata Chemical compounds in some food or beverages, like green tea, muscadine grapes, and dark chocolate have been known to bind to and block the function of a protease, in the SARS-CoV-2 virus, according to researchers. Proteases are essential to the health and viability of cells and viruses. On the […]

Read More
  • BiotechToday
  • World

DRY SWAB-DIRECT RT-PCR TO RAMP UP TEST FREQUENCY

bioxone December 3, 2020December 3, 2020 1

RUCHITA KARMAKAR, AMITY UNIVERSITY KOLKATA The Indian Council of Medical Research (ICMR) agreed a dry swab-direct RT-PCR testing method for the COVID-19 virus which is presently developed by CSIR-Centre for Cellular and Molecular Biology (CCMB). This new method of dry swab-direct test aimed at ascending the test by atleast two to three folds with no […]

Read More
  • BiotechToday
  • World

None of the SARS-CoV-2 Genetic Mutations Appear to Increase Transmissibility

bioxone December 2, 2020December 2, 2020 4

SAGNIK NAG, Amity University, Kolkata SARS-CoV-2 is a type of RNA virus, which can develop mutations by three different ways: by making mistake from copying errors during viral replication, through interactions with other viruses infecting the same cell i.e. recombination, or they can be also induced by host RNA modification systems which are part of […]

Read More
  • BiotechToday
  • World

Lapatinib, Doramapimod with Remdesivir teamed against COVID-19

bioxone December 1, 2020December 1, 2020 1

Souradip Mallick, National Institute of Technology, Rourkela The emergence of SARS-CoV-2 virus has resulted in a worldwide pandemic killed over 1,368,000 people globally (WHO). Currently, effective treatments to inhibit SARS-CoV-2 morbidity and mortality are not available. The pharmacological screen identified several compounds capable of blocking the in vitro replication of two beta-coronaviruses. Among many ones […]

Read More

Posts navigation

1 … 3 4 5 6 7 8 9 10 11 … 13

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy